Objective: To describe the genotypic variability of group A rotavirus (RVA) found in immunosuppressed and non-immunosuppressed pediatric patients treated at the Hospital de Clínicas da Universidade Federal do Paraná (HC-UFPR), Curitiba, Paraná.

Methods: A cross-sectional study was conducted with 1,140 stool samples collected from April, 2001 to December, 2008 in outpatients and hospitalized patients with acute gastroenteritis referred to the hospital. RVA diagnosis was performed through the latex agglutination method and enzyme immunoassay. Reverse transcription followed by multiplex hemi-nested polymerase chain reaction (PCR) and nucleotide sequencing were used for genotype characterization. Genotype combinations, clinical, epidemiological, laboratory data, and presence of hospital-acquired infections were reported.

Results: A total of 80 rotavirus-positive stool samples were analyzed. The most frequent associations between genotypes G and P were: G4 P[8] (38.9%), G1 P[8] (30.5%), G9 P[8] (13.9%), G2 P[4] (6.9%), and G3 P[8] (1.4%). G2 P[4] was the most prevalent genotype after the vaccine implementation in the years 2006 and 2008. A total of 62,5% of infected children were aged less than 12 months. Of these, 55.6% had severe dehydration and 26.7% needed intensive care. A frequency of 12.5% of nosocomial infections was found. No correlation was observed between genotype and severity of infection in the study patients.

Conclusion: RVA infections can be associated with severe clinical manifestations, and the surveillance of genotypic variability of this virus is crucial to monitor the emergence of new strains and the impact of the immunization in these patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jped.2012.11.002DOI Listing

Publication Analysis

Top Keywords

immunosuppressed non-immunosuppressed
8
non-immunosuppressed pediatric
8
pediatric patients
8
genotypic variability
8
stool samples
8
molecular characterization
4
characterization rotavirus
4
rotavirus genotypes
4
genotypes immunosuppressed
4
patients
4

Similar Publications

Primary Cutaneous Rhabdoid Squamous Cell Carcinoma: A Case Report and Review of Molecular Features.

Cureus

November 2024

Dermatopathology, Regional Medical Laboratory and Pathology Laboratory Associates, Tulsa, USA.

We present a rare case of rhabdoid squamous cell carcinoma (RSCC) on the scalp of a non-immunosuppressed male patient in his late 60s. This aggressive variant of squamous cell carcinoma (SCC) is characterized by tumor cells with eccentrically located nuclei and abundant eosinophilic cytoplasm, as observed on histopathological examination. While rhabdoid morphology has been reported in various anatomical sites, its occurrence in primary cutaneous tumors is exceptionally uncommon, with fewer than 10 cases documented to date.

View Article and Find Full Text PDF
Article Synopsis
  • - High levels of antibodies to interferon-gamma (IFN-γ) are linked to infections from intracellular pathogens, especially non-tuberculous mycobacteria (NTM) and tuberculosis (MTB).
  • - The case study discusses a non-immunosuppressed patient who had both MTB infection and complications from NTM, which led to a severe condition called secondary hemophagocytic syndrome.
  • - The report emphasizes the importance of recognizing this uncommon combination of infections to prevent misdiagnosis or unnecessary treatments for patients.
View Article and Find Full Text PDF

Multicenter systematic review of clinical characteristics, diagnostic optimization, and personalized treatment for brain Nocardia infections.

Microb Pathog

January 2025

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address:

Article Synopsis
  • - This systematic review analyzes 512 cases of Nocardia brain infections from 2000 to mid-2024, focusing on clinical symptoms, imaging results, and antibiotic resistance patterns in both immunocompromised and non-immunocompromised patients.
  • - It highlights the shortcomings of traditional microbiological cultures in diagnosing these infections compared to advanced molecular methods, which improve detection speed and accuracy.
  • - Key factors for better treatment outcomes include timely antibiotic administration (notably sulfonamides and β-lactams) and the potential need for surgical intervention, emphasizing the importance of improved diagnostic and treatment strategies.
View Article and Find Full Text PDF

The incidence of colon diverticulosis and diverticulitis is increasing. This review summarises the current classification and treatment options. Antibiotic treatment is not indicated for uncomplicated diverticulitis in non-immunosuppressed patients.

View Article and Find Full Text PDF

Genomic evidence of gut population diversity translocation in leukemia patients.

mSphere

October 2024

Université Paris Cité, INSERM, IAME, and APHP, Hôpital Bichat, Laboratoire de Génétique Moléculaire, Paris, France.

a commensal species of the human gut, is an opportunistic pathogen that can reach extra-intestinal compartments, including the bloodstream and the bladder, among others. In non-immunosuppressed patients, purifying or neutral evolution of populations has been reported in the gut. Conversely, it has been suggested that when migrating to extra-intestinal compartments, genomes undergo diversifying selection as supported by strong evidence for adaptation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!